In the present study, the effects of 17beta-estradiol (E2) and phytoestrogen alpha-zearalanol (ZAL) on tissue factor (TF) in plasma of ovariectomized (OVX) rats and human umbilical vein endothelial cells (HUVECs) were investigated. OVX rats were injected intramuscularly twice a week with E2 (1mg/kg) or ZAL (1mg/kg) for five weeks. The concentrations of plasma E2 were measured by radioimmunoassay. The TF levels of plasma were assayed by enzyme-linked immunosorbent assay (ELISA). HUVECs were exposed to E2 or ZAL for 48 h. TF protein and mRNA were assayed by ELISA and RT-PCR, respectively. Nuclear proteins of HUVECs opposed to E2 or ZAL for 8 h were extracted to assay transcription factors activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) by Western blot. Both E2 and ZAL were found to decrease plasma TF levels of OVX rats significantly. E2 or ZAL were also found down-regulate the expression of TF protein and mRNA in HUVECs. Moreover, both E2 and ZAL might decrease AP-1 and NF-kappaB levels. These results suggest that both E2 and ZAL have inhibitory effects on TF in plasma of OVX rats and HUVECs, which may then contribute to their protective effects on cardiovascular diseases.
Download full-text PDF |
Source |
---|
Chin J Nat Med
January 2025
The First Clinical Academy, Guangzhou University of Chinese Medicine, Guangzhou 510405, China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510407, China; Lingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Electronic address:
Osteoporosis is a prevalent skeletal condition characterized by reduced bone mass and strength, leading to increased fragility. Buqi-Tongluo (BQTL) decoction, a traditional Chinese medicine (TCM) prescription, has yet to be fully evaluated for its potential in treating bone diseases such as osteoporosis. To investigate the mechanism by which BQTL decoction inhibits osteoclast differentiation in vitro and validate these findings through in vivo experiments.
View Article and Find Full Text PDFJ Gene Med
January 2025
Department of Orthopedic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen City, Guangdong, China.
Purpose: Postmenopausal osteoporosis (PMO) is mainly concerned with the imbalance of bone resorption and bone formation. Icariin (ICA) plays a vital role in bone protection. This study investigated the mechanism of ICA in PMO rats.
View Article and Find Full Text PDFJ Cell Mol Med
January 2025
Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Postmenopausal osteoporosis (PMOP) is a chronic systemic bone metabolism disorder. Promotion in the patterns of human bone marrow mesenchymal stem cells (hBMSCs) differentiation towards osteoblasts contributes to alleviating osteoporosis. Aucubin, a natural compound isolated from the well-known herbal medicine Eucommia, was previously shown to possess various pharmacological effects.
View Article and Find Full Text PDFComb Chem High Throughput Screen
January 2025
Department of Orthopedics, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, China.
Background: Postmenopausal Osteoporosis (PMOP) is characterized by decreased bone mass and deterioration of bone microarchitecture, leading to increased fracture risk. Current treatments often have adverse effects, necessitating safer alternatives. Kaempferol, a flavonoid identified as a key active component of the traditional Chinese medicine Yishen Gushu formula, has shown promise in improving bone health, but its mechanisms in PMOP treatment remain unclear.
View Article and Find Full Text PDFElife
January 2025
Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Estrogen significantly impacts women's health, and postmenopausal hypertension is a common issue characterized by blood pressure fluctuations. Current control strategies for this condition are limited in efficacy, necessitating further research into the underlying mechanisms. Although metabolomics has been applied to study various diseases, its use in understanding postmenopausal hypertension is scarce.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!